Plant-derived nanotherapeutic systems to counter the overgrowing threat of resistant microbes and biofilms

• Published in: Advanced drug delivery reviews Vol. 179; p. 114019
• Main Authors: Asghar, Sajid, Khan, Ikram Ullah, Salman, Saad, Khalid, Syed Haroon, Ashfaq, Rabia, Vandamme, Thierry F.
• Format: Journal Article
• Language: English
• Published: Netherlands Elsevier B.V 01.12.2021
• Subjects: Anti-Bacterial Agents - administration & dosage; Anti-Bacterial Agents - chemistry; Anti-Bacterial Agents - pharmacology; Antimicrobial resistance; Biofilms - drug effects; Biofilms - growth & development; Biofouling; Cross Infection - microbiology; Drug Carriers; Drug delivery; Drug Liberation; Drug Resistance, Multiple, Bacterial - physiology; Drug Stability; Equipment and Supplies - microbiology; Humans; Nanoparticle Drug Delivery System - chemistry; Nanotechnology; Particle Size; Physicochemical properties; Phytochemicals; Phytochemicals - administration & dosage; Phytochemicals - chemistry; Phytochemicals - pharmacology; A. flavus; CRKP; FRCA; S. flexneri; S. mutans; S. gordonii; A. sobria; Pd; SeO; A. baumannii; C. diphtheria; S. epidermidis; QS; SDT; VRSA; Pt; SWCNTs; MIC; G. mellonella; US CDC; MSNs; S. enteritidis; A. radioresistens; E. faecalis; H. influenzae; S. boydii; S. senftenberg; A. naeslundii; A. fumigatus; Ag; DNase; S. cumini; MSSA; S. aureus; Au; CNTs; S. nigrescens; A. oryzae; E. coli; CD; A. oris; TB; B. cereus; Se; Si; ICR; S. sanguinis; Nanotechnology; Xag; Ber-rhe; K. oxytoca; L. acidophilus; H. pylori; E. cloacae; E-DNA; Cu; SARS-CoV-2; S. pneumoniae; MRSE; S. enterica; Ti; A. solani; MRSA; M. fortuitum; XS2–y; BBR-WOG; C. membranifaciens; K. pneumoniae; C. glabrata; P. acnes; PP-PEI; P. mirabilis; C. guilliermondi; L. monocytogenes; M. smegmatis; C. violaceum; MWCNTs; PTA; R. solanacearum; B. pseudomallei; C. jejuni; Balb/c; QDs; B. licheniformis; IgG; APTES; S. suis; CdTe; B. subtilis; C. freundii; E. aerogenes; P. gingivalis; PTT; P. cepacia; GA; Fe; P. aeruginosa; PDT; DSPE; ADME; MOF; GO; T. rubrum; NPs; E. carotovora; DNA; P. vulgaris; S. pyogenes; E. hormaechei; MIL-125; S. marcescens; V. dispar; VRE; EPS; CARG; B. pertussis; SACT; C. krusei; T. denticola; M. tuberculosis; LIFU; Phytochemicals; F. nucleatum; S. haemolyticus; Physicochemical properties; TiO2; C. utilis; L. plantarum; DPN; C. dubliniensis; A. parasiticus; UiO-66; M. avium; MBC; P. fluorescens; FeO; B. pumilis; CREC; Zn; ESBL; V. philippica; S. typhimurium; C. neoformans; S. dysenteriae; N. gonorrhoeae; mAb; HIV; S. sciuri; V. parahaemolyticus; ZnO; I. simonsii Maxim; A. tumefaciens; P. granatum; ZnS; C. cyminum; A. niger; M. abscessus; RNA; M. gypseum; M. luteus; MDR; A. hydrophila; WHO; AMP; B. fragilis; V. cholerae; PBPs; CRB; C. albicans; Biofouling; CRE; ROS; BBR-BA; N. procumbens; TCM; Mn; PLA; Drug delivery; M. canis; S. intermedius; LDL; NiO; Spd-CQDs; Ni; CA-BBR; L. tropica; C. parapsilosis; M. massiliense; PLGA; C. tropicalis; ZIF-8; NIR; Antimicrobial resistance; COVID 19; CuO; A. anitratus
• ISSN: 0169-409X; 1872-8294
• DOI: 10.1016/j.addr.2021.114019

[Display omitted] Since antiquity, the survival of human civilization has always been threatened by the microbial infections. An alarming surge in the resistant microbial strains against the conventional drugs is quite evident in the preceding years. Furthermore, failure of currently available regimens of antibiotics has been highlighted by the emerging threat of biofilms in the community and hospital settings. Biofilms are complex dynamic composites rich in extracellular polysaccharides and DNA, supporting plethora of symbiotic microbial life forms, that can grow on both living and non-living surfaces. These enforced structures are impervious to the drugs and lead to spread of recurrent and non-treatable infections. There is a strong realization among the scientists and healthcare providers to work out alternative strategies to combat the issue of drug resistance and biofilms. Plants are a traditional but rich source of effective antimicrobials with wider spectrum due to presence of multiple constituents in perfect synergy. Other than the biocompatibility and the safety profile, these phytochemicals have been repeatedly proven to overcome the non-responsiveness of resistant microbes and films via multiple pathways such as blocking the efflux pumps, better penetration across the cell membranes or biofilms, and anti-adhesive properties. However, the unfavorable physicochemical attributes and stability issues of these phytochemicals have hampered their commercialization. These issues of the phytochemicals can be solved by designing suitably constructed nanoscaled structures. Nanosized systems can not only improve the physicochemical features of the encapsulated payloads but can also enhance their pharmacokinetic and therapeutic profile. This review encompasses why and how various types of phytochemicals and their nanosized preparations counter the microbial resistance and the biofouling. We believe that phytochemical in tandem with nanotechnological innovations can be employed to defeat the microbial resistance and biofilms. This review will help in better understanding of the challenges associated with developing such platforms and their future prospects.